ArticleBMC women's health2026
The impact of histopathologically proven adenomyosis on surgical outcomes and total laparoscopic hysterectomy complication rates, types, and severity.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Twelve-month pelvic pain after ovarian-preserving laparoscopic hysterectomy: Secondary analysis of a randomized trial of hyaluronic acid gel.European journal of obstetrics & gynecology and reproductive biology: X · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo compare the surgical outcomes and complications of patients with and without a histopathologic diagnosis of adenomyosis after total laparoscopic hysterectomy (TLH).
methodsA retrospective single-centre cohort study was conducted at the SanlıurfaTraining and Research Hospital to evaluate the histopathologic results of patients who underwent TLH for benign disease between January 2018 and August 2025. The patients were divided into two groups according to their postoperative histopathologic results (Group 1: adenomyosis, Group 2: without adenomyosis). We considered postoperative major surgical complications according to the Clavien–Dindo (CD) score. A logistic regression model was applied to estimate the association between the presence of adenomyosis and primary outcomes.
resultsA total of 332 patients underwent TLH, of whom 135 (40.7%) were in Group 1, and 197 (59.3%) were in Group 2. Patients with adenomyosis were less likely to report a total complication rate (OR 0.97, 95% CI 0.60–1.57, P = 0.913) and postoperative complications (OR 0.92, 95% CI 0.55–1.53, P = 0.766). However, they were more likely to report intraoperative complications (OR 1.26, 95% CI 0.41–3.84, P = 0.682). According to the CD score, the effect of adenomyosis was slightly lower in grade 1 complications (OR 0.50, 95% CI 0.17–1.43, P = 0.197) and similar in grade 2 and grade ≥ 3 complications (OR 1.03, CI 0.58–1.84, P = 0.903; OR 2.52, CI 0.64–9.83, P = 0.183). Patients with adenomyosis had a slightly higher risk of urinary tract/bladder injuries, bowel injuries, and vaginal cuff dehiscence (respectively, OR 1.78, 95% CI 0.53–5.97, P = 0.347; OR 4.45, 95% CI 0.45–43.28, P = 0.198; OR 1.47, 95% CI 0.29–7.39, P = 0.640).
conclusionsThe present study showed that there was no significant difference in total complication rate, severity (CD score), and types of complications between patients with and without histopathologically proven adenomyosis who underwent TLH for benign disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.